Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12694 | 887 | 38.1 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
139 | 3 | THYROID//THYROID CANCER//GRAVES DISEASE | 64904 |
224 | 2 | GRAVES DISEASE//THYROID//CONGENITAL HYPOTHYROIDISM | 20534 |
12694 | 1 | SODIUM IODIDE SYMPORTER//SODIUM IODIDE SYMPORTER NIS//IODIDE TRANSPORT | 887 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SODIUM IODIDE SYMPORTER | authKW | 3396656 | 16% | 72% | 138 |
2 | SODIUM IODIDE SYMPORTER NIS | authKW | 474801 | 2% | 69% | 20 |
3 | IODIDE TRANSPORT | authKW | 428506 | 2% | 66% | 19 |
4 | NIS | authKW | 409974 | 6% | 23% | 52 |
5 | NA I SYMPORTER | authKW | 306676 | 2% | 64% | 14 |
6 | HNIS | authKW | 240968 | 1% | 100% | 7 |
7 | IODIDE TRANSPORT DEFECT | authKW | 172120 | 1% | 100% | 5 |
8 | RADIOIODIDE THERAPY | authKW | 154905 | 1% | 75% | 6 |
9 | RADIOIODIDE | authKW | 149658 | 1% | 43% | 10 |
10 | IODIDE UPTAKE | authKW | 148747 | 1% | 39% | 11 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 8984 | 39% | 0% | 345 |
2 | Radiology, Nuclear Medicine & Medical Imaging | 829 | 13% | 0% | 114 |
3 | Oncology | 771 | 17% | 0% | 150 |
4 | Medicine, Research & Experimental | 707 | 11% | 0% | 102 |
5 | Genetics & Heredity | 168 | 7% | 0% | 63 |
6 | Biotechnology & Applied Microbiology | 133 | 7% | 0% | 59 |
7 | Biochemistry & Molecular Biology | 81 | 13% | 0% | 112 |
8 | Cell Biology | 78 | 7% | 0% | 61 |
9 | Pathology | 26 | 2% | 0% | 20 |
10 | Physiology | 15 | 2% | 0% | 22 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TIRO | 140559 | 1% | 58% | 7 |
2 | BIOORGAN CHEM ISOTOP ELLING | 137696 | 0% | 100% | 4 |
3 | BRAHMS DIAGNOST | 68848 | 0% | 100% | 2 |
4 | CARCINOGENESIS SKIN | 68848 | 0% | 100% | 2 |
5 | CEA DSV IBEB SBTNCAL | 68848 | 0% | 100% | 2 |
6 | CNRSUMR 6078 | 68848 | 0% | 100% | 2 |
7 | UNIDAD TUMO ENDOCRINOS | 68848 | 0% | 100% | 2 |
8 | U948 | 62463 | 1% | 26% | 7 |
9 | BIOL TECHNOL IBITECS | 61194 | 0% | 44% | 4 |
10 | CLIN COOPERAT UNIT RADIAT THER Y | 51633 | 0% | 50% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THYROID | 24310 | 6% | 1% | 51 |
2 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 6467 | 8% | 0% | 67 |
3 | NUCLEAR MEDICINE AND BIOLOGY | 4097 | 2% | 1% | 21 |
4 | EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 3822 | 2% | 1% | 16 |
5 | EUROPEAN JOURNAL OF ENDOCRINOLOGY | 3489 | 3% | 0% | 23 |
6 | CANCER GENE THERAPY | 3422 | 2% | 1% | 14 |
7 | MOLECULAR IMAGING | 2736 | 1% | 1% | 6 |
8 | JOURNAL OF NUCLEAR MEDICINE | 2434 | 3% | 0% | 27 |
9 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2397 | 2% | 0% | 15 |
10 | CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 2343 | 1% | 1% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SODIUM IODIDE SYMPORTER | 3396656 | 16% | 72% | 138 | Search SODIUM+IODIDE+SYMPORTER | Search SODIUM+IODIDE+SYMPORTER |
2 | SODIUM IODIDE SYMPORTER NIS | 474801 | 2% | 69% | 20 | Search SODIUM+IODIDE+SYMPORTER+NIS | Search SODIUM+IODIDE+SYMPORTER+NIS |
3 | IODIDE TRANSPORT | 428506 | 2% | 66% | 19 | Search IODIDE+TRANSPORT | Search IODIDE+TRANSPORT |
4 | NIS | 409974 | 6% | 23% | 52 | Search NIS | Search NIS |
5 | NA I SYMPORTER | 306676 | 2% | 64% | 14 | Search NA+I+SYMPORTER | Search NA+I+SYMPORTER |
6 | HNIS | 240968 | 1% | 100% | 7 | Search HNIS | Search HNIS |
7 | IODIDE TRANSPORT DEFECT | 172120 | 1% | 100% | 5 | Search IODIDE+TRANSPORT+DEFECT | Search IODIDE+TRANSPORT+DEFECT |
8 | RADIOIODIDE THERAPY | 154905 | 1% | 75% | 6 | Search RADIOIODIDE+THERAPY | Search RADIOIODIDE+THERAPY |
9 | RADIOIODIDE | 149658 | 1% | 43% | 10 | Search RADIOIODIDE | Search RADIOIODIDE |
10 | IODIDE UPTAKE | 148747 | 1% | 39% | 11 | Search IODIDE+UPTAKE | Search IODIDE+UPTAKE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HINGORANI, M , SPITZWEG, C , VASSAUX, G , NEWBOLD, K , MELCHER, A , PANDHA, H , VILE, R , HARRINGTON, K , (2010) THE BIOLOGY OF THE SODIUM IODIDE SYMPORTER AND ITS POTENTIAL FOR TARGETED GENE DELIVERY.CURRENT CANCER DRUG TARGETS. VOL. 10. ISSUE 2. P. 242-267 | 118 | 67% | 55 |
2 | MICALI, S , BULOTTA, S , PUPPIN, C , TERRITO, A , NAVARRA, M , BIANCHI, G , DAMANTE, G , FILETTI, S , RUSSO, D , (2014) SODIUM IODIDE SYMPORTER (NIS) IN EXTRATHYROIDAL MALIGNANCIES: FOCUS ON BREAST AND UROLOGICAL CANCER.BMC CANCER. VOL. 14. ISSUE . P. - | 88 | 79% | 10 |
3 | SPITZWEG, C , MORRIS, JC , (2002) THE SODIUM IODIDE SYMPORTER: ITS PATHOPHYSIOLOGICAL AND THERAPEUTIC IMPLICATIONS.CLINICAL ENDOCRINOLOGY. VOL. 57. ISSUE 5. P. 559-574 | 97 | 89% | 102 |
4 | DOHAN, O , DE LA VIEJA, A , PARODER, V , RIEDEL, C , ARTANI, M , REED, M , GINTER, CS , CARRASCO, N , (2003) THE SODIUM/IODIDE SYMPORTER (NIS): CHARACTERIZATION, REGULATION, AND MEDICAL SIGNIFICANCE.ENDOCRINE REVIEWS. VOL. 24. ISSUE 1. P. 48-77 | 106 | 55% | 389 |
5 | DARROUZET, E , LINDENTHAL, S , MARCELLIN, D , PELLEQUER, JL , POURCHER, T , (2014) THE SODIUM/IODIDE SYMPORTER: STATE OF THE ART OF ITS MOLECULAR CHARACTERIZATION.BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. VOL. 1838. ISSUE 1. P. 244-253 | 85 | 69% | 8 |
6 | SPITZWEG, C , MORRIS, JC , (2010) GENETICS AND PHENOMICS OF HYPOTHYROIDISM AND GOITER DUE TO NIS MUTATIONS.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 322. ISSUE 1-2. P. 56-63 | 64 | 94% | 26 |
7 | PORTULANO, C , PARODER-BELENITSKY, M , CARRASCO, N , (2014) THE NA+/I- SYMPORTER (NIS): MECHANISM AND MEDICAL IMPACT.ENDOCRINE REVIEWS. VOL. 35. ISSUE 1. P. 106-149 | 113 | 40% | 33 |
8 | KOGAI, T , BRENT, GA , (2012) THE SODIUM IODIDE SYMPORTER (NIS): REGULATION AND APPROACHES TO TARGETING FOR CANCER THERAPEUTICS.PHARMACOLOGY & THERAPEUTICS. VOL. 135. ISSUE 3. P. 355 -370 | 100 | 52% | 40 |
9 | RIESCO-EIZAGUIRRE, G , SANTISTEBAN, P , (2006) A PERSPECTIVE VIEW OF SODIUM IODIDE SYMPORTER RESEARCH AND ITS CLINICAL IMPLICATIONS.EUROPEAN JOURNAL OF ENDOCRINOLOGY. VOL. 155. ISSUE 4. P. 495-512 | 86 | 69% | 90 |
10 | PENHEITER, AR , RUSSELL, SJ , CARLSON, SK , (2012) THE SODIUM IODIDE SYMPORTER (NIS) AS AN IMAGING REPORTER FOR GENE, VIRAL, AND CELL-BASED THERAPIES.CURRENT GENE THERAPY. VOL. 12. ISSUE 1. P. 33-47 | 85 | 52% | 33 |
Classes with closest relation at Level 1 |